| Primary |
| Drug Use For Unknown Indication |
41.7% |
| Product Used For Unknown Indication |
27.3% |
| Hyperlipidaemia |
8.5% |
| Dyslipidaemia |
7.3% |
| Hypertension |
3.7% |
| Hypertriglyceridaemia |
2.2% |
| Hypercholesterolaemia |
1.7% |
| Blood Cholesterol Increased |
1.2% |
| Type 2 Diabetes Mellitus |
1.1% |
| Blood Triglycerides Increased |
1.0% |
| Mixed Hyperlipidaemia |
0.7% |
| Drug Exposure During Pregnancy |
0.7% |
| Diabetes Mellitus |
0.6% |
| Depression |
0.5% |
| Osteoporosis |
0.3% |
| Blood Cholesterol |
0.3% |
| Lipids Abnormal |
0.3% |
| Pain |
0.3% |
| Congestive Cardiomyopathy |
0.3% |
| Herpes Zoster |
0.3% |
|
| Rhabdomyolysis |
15.3% |
| Hepatic Function Abnormal |
11.7% |
| Liver Disorder |
11.5% |
| High Density Lipoprotein Decreased |
6.8% |
| Accidental Exposure |
5.8% |
| Renal Failure Acute |
4.9% |
| Renal Impairment |
4.9% |
| Gamma-glutamyltransferase Increased |
4.0% |
| Jaundice |
3.8% |
| Liver Function Test Abnormal |
3.6% |
| Transaminases Increased |
3.6% |
| Myalgia |
3.1% |
| Pulmonary Embolism |
3.1% |
| Pyrexia |
3.1% |
| Rash |
3.1% |
| Malaise |
2.9% |
| Completed Suicide |
2.6% |
| Drug Interaction |
2.0% |
| Renal Failure |
2.0% |
| Weight Decreased |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
36.1% |
| Drug Use For Unknown Indication |
15.9% |
| Hypertension |
6.7% |
| Blood Cholesterol Increased |
4.9% |
| Dyslipidaemia |
4.4% |
| Hypercholesterolaemia |
4.4% |
| Hyperlipidaemia |
4.4% |
| Diabetes Mellitus |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Lymphangioma |
2.4% |
| Asthma |
2.2% |
| Hiv Infection |
2.2% |
| Hypertriglyceridaemia |
1.6% |
| Blood Triglycerides Increased |
1.6% |
| Depression |
1.2% |
| Congestive Cardiomyopathy |
1.2% |
| Osteoporosis |
1.0% |
| Weight Control |
0.8% |
| Completed Suicide |
0.8% |
| Type Iia Hyperlipidaemia |
0.8% |
|
| Myalgia |
10.7% |
| High Density Lipoprotein Decreased |
9.2% |
| Rhabdomyolysis |
9.2% |
| Renal Failure Acute |
8.9% |
| Completed Suicide |
8.3% |
| Pancreatitis Acute |
7.1% |
| White Blood Cell Count Decreased |
5.3% |
| Renal Failure |
4.7% |
| Vomiting |
4.5% |
| Drug Interaction |
4.2% |
| Sleep Disorder |
3.9% |
| Toxic Epidermal Necrolysis |
3.6% |
| Lung Disorder |
3.0% |
| Melaena |
3.0% |
| Weight Decreased |
3.0% |
| Pyrexia |
2.7% |
| Thyroid Disorder |
2.7% |
| Jaundice |
2.1% |
| Liver Function Test Abnormal |
2.1% |
| Myositis |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.6% |
| Drug Use For Unknown Indication |
20.5% |
| Hypertension |
8.4% |
| Diabetes Mellitus |
4.5% |
| Blood Cholesterol Increased |
4.5% |
| Type 2 Diabetes Mellitus |
3.3% |
| Depression |
3.2% |
| Hiv Infection |
3.2% |
| Pain |
2.7% |
| Rheumatoid Arthritis |
2.1% |
| Blood Triglycerides Increased |
2.0% |
| Anxiety |
1.9% |
| Hyperlipidaemia |
1.8% |
| Atrial Fibrillation |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Prophylaxis |
1.5% |
| Blood Cholesterol |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Insomnia |
1.0% |
| Osteoporosis |
1.0% |
|
| Flushing |
11.5% |
| Vomiting |
11.5% |
| Pruritus |
7.5% |
| Weight Decreased |
7.3% |
| Weight Increased |
6.0% |
| Renal Failure Acute |
5.8% |
| Nausea |
5.1% |
| Drug Ineffective |
4.6% |
| Renal Failure |
4.4% |
| Myocardial Infarction |
3.9% |
| Rash |
3.8% |
| Paraesthesia |
3.6% |
| Pancreatitis Acute |
3.5% |
| Death |
3.4% |
| Myalgia |
3.2% |
| Pain In Extremity |
3.1% |
| Blood Glucose Increased |
3.1% |
| Dyspnoea |
3.0% |
| Malaise |
3.0% |
| Pyrexia |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
16.8% |
| Dyslipidaemia |
11.1% |
| Hypercholesterolaemia |
11.1% |
| Hypertriglyceridaemia |
10.2% |
| Deep Vein Thrombosis |
9.8% |
| Depression |
7.4% |
| Chest Pain |
4.9% |
| Hypertension |
4.5% |
| Schizophrenia |
3.7% |
| Type Iia Hyperlipidaemia |
3.3% |
| Atrial Fibrillation |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Pain |
2.5% |
| Pain In Extremity |
2.5% |
| Coronary Artery Disease |
1.6% |
| Immunosuppression |
1.6% |
| Lipids Abnormal |
1.6% |
| Angina Pectoris |
0.8% |
| Blood Triglycerides Increased |
0.8% |
| Hyperlipidaemia |
0.8% |
|
| Drug Interaction |
32.8% |
| High Density Lipoprotein Decreased |
22.4% |
| Rhabdomyolysis |
13.4% |
| Febrile Neutropenia |
4.5% |
| Haemorrhage |
3.0% |
| Tremor |
3.0% |
| Blood Lactate Dehydrogenase Increased |
1.5% |
| Ecchymosis |
1.5% |
| Haematuria |
1.5% |
| Hypovolaemic Shock |
1.5% |
| Myalgia |
1.5% |
| Myopathy |
1.5% |
| Paraesthesia |
1.5% |
| Renal Failure Acute |
1.5% |
| Spinal Epidural Haemorrhage |
1.5% |
| Spinal Haematoma |
1.5% |
| Subcutaneous Haematoma |
1.5% |
| Swelling |
1.5% |
| Transaminases Increased |
1.5% |
| White Blood Cell Count Decreased |
1.5% |
|
